News

The American Diabetes Association issues new guidance, "Hemoglobin A1C Targets for Glycemic Control with Pharmacologic Therapy for Nonpregnant Adults with Type 2 Diabetes Mellitus: A…
Read More...

Biotech company based in Dayton,OH has received IRB approval to initiate a Clinical case series studying spinal cord stimulator alogrithms in patients afflicted with back pain.…
Read More...

Wuxi NextCODE which is an emerging global standard platform for genomic data asserted a partnership with Google Cloud that focuses to deliver comprehensive genomics capabilities to…
Read More...

IQuity has declared the release of IsolateFibromyalgia which is a pioneering blood test that utilizes RNA analysis to aid health care providers accurately and quickly ascertain …
Read More...

CrossRoads Extremity Systems which is privately held medical device company offering innovative foot & ankle fixation implant systems and services asserted that it has recently…
Read More...

Leica Biosystems declared the release of a remarkable update to the highly regarded BOND-III IHC and ISH stainer. The latest advance to the BOND-III stainer incorporates a unique set…
Read More...

Orthofix International declared the U.S. Food and Drug Administration (FDA) and European CE Mark approvals for its next-generation PhysioStim bone growth stimulators. The PhysiStim…
Read More...

Global life sciences company and a global leader in mammalian cell line generation technology, Selexis SA asserted that Compugen has obtained license to the Selexis SUREtechnology …
Read More...

Premier Biotech was awarded a 510 (k) clearance for the following drugs Amphetamine, Cocaine, Marijuana, Methamphetamine, Opiates and Phencyclidine from the Food and Drug Administration…
Read More...

MYM Nutraceuticals appoints Dr. Charith Adkar as its Chief Science Officer effective immediately. Dr. Adkar has pursued his PhD in Plant Biology and Crop Production from the…
Read More...

The Pharmaceutical Care Management Association has issued the following response to the remarks made by the FDA Commissioner Scott Gottlieb. The response issued was "In an era of…
Read More...

FDA Commissioner, Scott Gottlieb affirmed that FDA vows to commit itself to addressing women's health issues by speaking directly to patients and their families about significant health…
Read More...

Zydus Cadila which is a leading innovation-driven, global healthcare provider asserted that it has entered into a definitive agreement with Medicure International which is subsidiary of…
Read More...

Perrigo Company asserted that it has received final approval from the U.S Food and Drug Administration for the store brand OTC equivalent of Muciinex DM Maximum Strength Guaifenesin and…
Read More...

Veloxis Pharmaceuticals asserted that it has submitted a supplemental New Drug Application to the U.S Food and Drug Administration seeking new indication for ENVARSUS XR (tacrolimus…
Read More...

Ligand Pharmaceuticals signed a license agreement extending Roivant sciences exclusive global rights to develop and commercialize LGD-6972, ligand's glucagon receptor antagonist. As…
Read More...

Biohaven Pharmaceuticals asserted that it has enrolled the first patient in a Phase 3 Clinical Trial of Zydis that is a orally dissolving tablet formulation of rimegepant for the…
Read More...

Apexigen which is clinical-stage bio pharmaceutical company and the Pediatric Brain Tumor Consortium (PBTC) announced a Clinical trial collaboration to assess and evaluate Apexigen's …
Read More...

Citius Pharmaceuticals which is a specialty pharmaceutical company announced that the Company is finalizing a higher potency corticosteroid in its steroid/anesthetic topical formulation…
Read More...

Forendo Pharma which is a drug development company developing novel oral treatments for endometriosis patients asserted the appointment of David Colpman as a Non-executive Director to…
Read More...